Posted by Global Biological Skin Substitutes Market Overview 2023-2028
The global biological skin substitutes market size reached US$ 302 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 481 Million by 2028, exhibiting a growth rate (CAGR) of 7.9% during 2023-2028
Advanced medical products known as biological skin substitutes are employed in the realms of wound care and tissue regeneration. These substitutes can be sourced from human or animal tissues, or they can be fabricated using bioengineered materials. Furthermore, they can be customized to align with the specific dimensions and contours of a patient’s wound. This remarkable technology offers an alternative to traditional skin grafts and plays a pivotal role in accelerating the healing process while mitigating the risk of infections and complications. Additionally, they contribute to aesthetically pleasing outcomes with minimal scarring. Due to their ability to shorten hospital stays and expedite recovery, there is a growing global demand for biological skin substitutes.
Global Biological Skin Substitutes Market Trends and Drivers:
The market is experiencing significant growth due to several key factors. Firstly, the geriatric population is witnessing a rising incidence of chronic wounds and age-related conditions, such as diabetic ulcers. This demographic shift is a major driver for market expansion. Additionally, the prevalence of vascular diseases is contributing to an increasing demand for wound care solutions. Biological skin substitutes play a crucial role in enhancing the healing process for individuals with chronic wounds. They not only expedite healing but also reduce the overall cost of wound care by minimizing complications and hospital stays, thus resulting in fewer medical interventions. Moreover, as patients take a more proactive role in their healthcare decisions, they seek treatments that offer a better quality of life and reduced discomfort. Biological skin substitutes align with this trend, providing a less painful and aesthetically pleasing approach to wound healing. Furthermore, ongoing advancements in tissue engineering and regenerative medicine are leading to the development of increasingly sophisticated biological skin substitutes. These products offer enhanced effectiveness and better outcomes for patients, further supporting market growth. As healthcare professionals and patients become more informed about the advantages of biological skin substitutes through educational initiatives and research findings, the market is poised for continued expansion. This growth is also driven by the growing global demand for advanced wound care solutions.
Global Biological Skin Substitutes Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are:
Integra LifeSciences, Mallinckrodt Pharmaceuticals, MIMEDX Group Inc., Organogenesis Holdings Inc., Smith & Nephew PLC, Stryker Corporation, Tissue Regenix Group. Vericel Corporation, etc.
The report segmented the market on the basis of region, type, application, and end user.
Breakup by Type:
- Human Donor Tissue-derived Products
- Acellular Animal-derived Products
Breakup by Application:
- Acute Wounds
- Chronic Wounds
Breakup by End User:
- Hospitals
- Outpatient Facilities
- Research and Manufacturing
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800